company background image
TUB logo

Financière de Tubize ENXTBR:TUB Stock Report

Last Price

€106.80

Market Cap

€4.8b

7D

1.9%

1Y

43.9%

Updated

16 Jun, 2024

Data

Company Financials

Financière de Tubize SA

ENXTBR:TUB Stock Report

Market Cap: €4.8b

TUB Stock Overview

Operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium.

TUB fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance3/6
Financial Health2/6
Dividends0/6

Financière de Tubize SA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Financière de Tubize
Historical stock prices
Current Share Price€106.80
52 Week High€109.20
52 Week Low€60.80
Beta0.44
1 Month Change10.10%
3 Month Change22.48%
1 Year Change43.94%
3 Year Change32.67%
5 Year Change73.66%
Change since IPO1,806.46%

Recent News & Updates

Recent updates

Could The Financière de Tubize SA (EBR:TUB) Ownership Structure Tell Us Something Useful?

Dec 12
Could The Financière de Tubize SA (EBR:TUB) Ownership Structure Tell Us Something Useful?

Shareholder Returns

TUBBE PharmaceuticalsBE Market
7D1.9%0.03%-2.3%
1Y43.9%18.5%-0.2%

Return vs Industry: TUB exceeded the Belgian Pharmaceuticals industry which returned 18.5% over the past year.

Return vs Market: TUB exceeded the Belgian Market which returned -0.2% over the past year.

Price Volatility

Is TUB's price volatile compared to industry and market?
TUB volatility
TUB Average Weekly Movement3.3%
Pharmaceuticals Industry Average Movement5.0%
Market Average Movement3.6%
10% most volatile stocks in BE Market7.0%
10% least volatile stocks in BE Market2.6%

Stable Share Price: TUB has not had significant price volatility in the past 3 months.

Volatility Over Time: TUB's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1928n/aEric Nyswww.financiere-tubize.be

Financière de Tubize SA operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium. The company was incorporated in 1928 and is based in Brussels, Belgium.

Financière de Tubize SA Fundamentals Summary

How do Financière de Tubize's earnings and revenue compare to its market cap?
TUB fundamental statistics
Market cap€4.75b
Earnings (TTM)€88.15m
Revenue (TTM)n/a

53.9x

P/E Ratio

0.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TUB income statement (TTM)
Revenue€0
Cost of Revenue€2.03m
Gross Profit-€2.03m
Other Expenses-€90.18m
Earnings€88.15m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Jul 25, 2024

Earnings per share (EPS)1.98
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio4.4%

How did TUB perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

49%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.